Chloride channels are necessary for full platelet phosphatidylserine exposure and procoagulant activity

被引:0
|
作者
M T Harper
A W Poole
机构
[1] School of Physiology and Pharmacology,
[2] Bristol Heart Institute,undefined
[3] Medical Sciences Building,undefined
[4] University of Bristol,undefined
来源
Cell Death & Disease | 2013年 / 4卷
关键词
necrosis; coagulation; platelets; thrombosis; chloride channels;
D O I
暂无
中图分类号
学科分类号
摘要
Platelets enhance thrombin generation at sites of vascular injury by exposing phosphatidylserine during necrosis-like cell death. Anoctamin 6 (Ano6) is required for Ca2+-dependent phosphatidylserine exposure and is defective in patients with Scott syndrome, a rare bleeding disorder. Ano6 may also form Cl− channels, though the role of Cl− fluxes in platelet procoagulant activity has not been explored. We found that Cl− channel blockers or removal of extracellular Cl− inhibited agonist-induced phosphatidylserine exposure. However, this was not due to direct inhibition of Ca2+-dependent scrambling since Ca2+ ionophore-induced phosphatidylserine exposure was normal. This implies that the role of Ano6 in Ca2+−dependent PS exposure is likely to differ from any putative function of Ano6 as a Cl− channel. Instead, Cl− channel blockade inhibited agonist-induced Ca2+ entry. Importantly, Cl− channel blockers also prevented agonist-induced membrane hyperpolarization, resulting in depolarization. We propose that Cl− entry through Cl− channels is required for this hyperpolarization, maintaining the driving force for Ca2+ entry and triggering full phosphatidylserine exposure. This demonstrates a novel role for Cl− channels in controlling platelet death and procoagulant activity.
引用
收藏
页码:e969 / e969
相关论文
共 50 条
  • [41] Procoagulant Activity of Blood and Endothelial Cells via Phosphatidylserine Exposure and Microparticle Delivery in Patients with Diabetic Retinopathy
    Su, Ying
    Chen, Jingli
    Dong, Zengxiang
    Zhang, Yan
    Ma, Ruishuang
    Kou, Junjie
    Wang, Feng
    Shi, Jialan
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (06) : 2411 - 2420
  • [42] Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes
    Chung, Seung-Min
    Bae, Ok-Nam
    Lim, Kyung-Min
    Noh, Ji-Yoon
    Lee, Moo-Yeol
    Jung, Yi-Sook
    Chung, Jin-Ho
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (02) : 414 - 421
  • [43] Senescent rabbit platelets have increased surface exposure of procoagulant phosphatidylserine which is associated with shortened platelet survival.
    Wang, H
    Bang, KWA
    Poon, KSV
    Mody, M
    Freedman, J
    Rand, ML
    BLOOD, 2002, 100 (11) : 66B - 66B
  • [44] A Role for Platelet TRPC Channels in the Ca2+ Response That Induces Procoagulant Activity
    Mahaut-Smith, Martyn P.
    SCIENCE SIGNALING, 2013, 6 (281)
  • [45] Cyclosporine enhances platelet procoagulant activity
    Tomasiak, Marian
    Rusak, Tomasz
    Gacko, Marek
    Stelmach, Halina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (06) : 1750 - 1756
  • [46] Platelet procoagulant activity in bleeding disorders
    Lassila, R.
    HAEMOPHILIA, 2015, 21 : 7 - 7
  • [47] PLATELET PROCOAGULANT ACTIVITY ASSOCIATED WITH PLATELET SHAPE CHANGE
    EHRMAN, M
    TOTH, E
    FROJMOVIC, M
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1978, 92 (03): : 393 - 401
  • [48] Neonatal platelet procoagulant activity.
    Israels, SJ
    McMillan-Ward, E
    BLOOD, 2002, 100 (11) : 78B - 79B
  • [49] Platelet procoagulant activity is independent of aggregation
    Rendu, F
    Lavie, P
    Saleun, S
    Lasne, D
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1995, 37 (06): : 327 - 331
  • [50] PLATELET SHAPE CHANGE RELEASES PLATELET PROCOAGULANT ACTIVITY
    EHRMAN, ML
    FROJMOVIC, M
    TOTH, E
    CLINICAL RESEARCH, 1977, 25 (03): : A338 - A338